Interv Akut Kardiol. 2002;1(1):37-40

Damage to the kidneys caused by contrast agents

Vojtěch Martínek
Interní klinika fakultní nemocnice Motol a 2. lékařské fakulty Univerzity Karlovy v Praze

Nephropathy due to the application of radio-contrast agents, called contrast nephropathy (CN), is determined by the development of acute renal failure or by the progression of pre-existing renal insufficiency within 24–72 hours after contrast agent administration. Serum creatinine usually rises 30 % above its previous level. In pathogenesis of CN relative hypoperfusion of renal medulla results in its subsequent ischemic injury. In majority of cases the diuresis continues and the decrease of renal function is reversible.

The incidence of CN in patients with normal renal function is very low, but increases with the severity of the pre-existing renal insufficiency and can reach even 40%. Patients with diabetic nephropathy and patients with reduced effectively circulating volume are exposed to an extraordinary high risk.

Sufficient hydration is a cornerstone in prevention of CN. High risk patients should recieve 0,45 % solution of NaCl at 1ml/kg/hour intravenously, 12 hours prior and after contrast administration. In patients with a severe renal insufficiency (mainly due to diabetic nephropathy) low-osmolar contrast agent should be used, maybe with consequent haemodialysis.

Keywords: contrast media, contrast nephropathy, acute renal failure.

Published: December 31, 2002  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Martínek V. Damage to the kidneys caused by contrast agents. Interv Akut Kardiol. 2002;1(1):37-40.
Download citation

References

  1. Almén T. The etiology of contrast media reactions. Invest Radiol 1994;29(Supp.1): 37-45. Go to original source...
  2. Yoshimasa Y, Fogo A, Beckman JK. Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion. Kidney Int 1992;41:1008-1015. Go to original source... Go to PubMed...
  3. Russo D, Minutolo R, Cianciaruso B, et al. Early effects of contrast media on renal haemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 1995;6:1451-1458. Go to original source... Go to PubMed...
  4. Brezis M, Heyman SN, Epstein FH. Determinants of intrarenal oxygenation. II. Haemodynamic effects. Am J Physiol 1994;267:1063-1068. Go to original source...
  5. Heyman SN, Brezis M, Epstein FH, et al. Early medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 1991;40:632-642. Go to original source... Go to PubMed...
  6. Weisberg LS, Kurnik PB, Kurnik BR. Radiocontrast-induced nephropathy in humans. Role of renal vasoconstriction. Kidney Int 1992;41:1408-1415. Go to original source... Go to PubMed...
  7. Cantley LG, Spokes K, Clark BA, et al. Role of endotelin and prostaglandins in radiocontrast-induced renal artery constrictions. Kidney Int 1993;44:1217-1223. Go to original source... Go to PubMed...
  8. Agmon Y, Peleg H, Greenfield Z, et al. Nitric oxide and prostanoids protect the renal outer medulla from radiocantrast toxicity in the rat. J Clin Invest 1994;94: 1069-1075. Go to original source... Go to PubMed...
  9. Solomon RC. Contrast-medium-induced acute renal failure. Kidney Int 1998;53: 230-242. Go to original source... Go to PubMed...
  10. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients:A randomized trial. Kidney Int 1995;47:254-61. Go to original source... Go to PubMed...
  11. Katholi RE, Taylor GJ, McCann WP, et al. Nephrotoxicity from contrast media. Attenuation with theopylline. Radiology 1995;195:7-22. Go to original source... Go to PubMed...
  12. Schwab SJ, Hlatky MA, Pieper KS, et al. Contrast nephrotoxicity:a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 1989;320:149-153. Go to original source... Go to PubMed...
  13. Moore RD, Steinberg EP, Rowe NR, et al. Nephrotoxicity of high-osmolality versus low-osmolality contrast media:Randomized clinical trial. Radiology 1992;182: 649-655. Go to original source... Go to PubMed...
  14. Davidson CJ, Hlatky M, Morris KG, et al. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent ofter cardiac catheterization. A prospective trial. Ann Int Med 1989;110:119-124. Go to original source... Go to PubMed...
  15. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. N Engl J Med 1989;320:143-149. Go to original source... Go to PubMed...
  16. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993;188:171-178. Go to original source... Go to PubMed...
  17. Barrett BJ. Contrast nephrotoxicity. J Am Soc Nephrol 1994;5:125-137. Go to original source... Go to PubMed...
  18. Manske CL, Sprafka JM, Strony JT. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990;89:615-620. Go to original source... Go to PubMed...
  19. Nunez BD, Allon M. Effect of cardiac catheterization on renal function. Clin Nephrol 1990;34:263-266. Go to PubMed...
  20. Moore RD, Steinberg EP, Powe NR, et al. Frequency and determinants of adverse reaction induced by high-osmolality contrast media. Radiology 1989;170:727-732. Go to original source... Go to PubMed...
  21. Miller DL, Chang R, Wells WT, et al. Intravascular contrast media:Effect of dose on renal function. Radiology 1988;167:607-611. Go to original source... Go to PubMed...
  22. Albert SG, Shapiro MJ, Brown WW, et al. Analysis of radio-contrast nephropathy by dual-labelled radionuclide clearance. Invest Radiol 1994;29:618-623. Go to original source... Go to PubMed...
  23. McCarthy, Becker JA. Multiple myeloma and contrast media. Radiology 1992;183: 519-521. Go to original source... Go to PubMed...
  24. Berns AS. Nephrology forum:Nephrotoxicity of contrast media. Kidney Int 1989;36:730-740. Go to original source... Go to PubMed...
  25. Parvez Z, Ramamurthy S, Patel NB, et al. Enzyme markers of contrast media induced renal failure. Invest Radiol 1990;25:133-134. Go to original source... Go to PubMed...
  26. Porter GA. Contrast associated nephropathy. Am J Cardiol 1989;64:22-26E. Go to original source... Go to PubMed...
  27. Jakobsen JA. Renal effects of iodixanol in healthy volunteers and patients with severe renal failure. Acta Radiol 1995;399(Suppl):191-195. Go to original source... Go to PubMed...
  28. Morcos SK, El.Nahas AM, Brown P, et al. Effect of iodinated water soluble contrast media on urinary protein assays. BMJ 1992;305:29-31. Go to original source... Go to PubMed...
  29. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996;275:1489-1494. Go to original source... Go to PubMed...
  30. Modi KS, Rao VK. Atheroembolic renal disease. J Am Soc Nephrol 2001;12: 1781-1789. Go to original source... Go to PubMed...
  31. Dachman AH. New contraindication to intravascular iodinated contrast material. Radiology 1995;197:545. Go to original source... Go to PubMed...
  32. Brown RS, Ransil B, Clark BA. Prehydration protects against contrast nephropathy in high risk patients undergoing cardiac catheterization. Am Soc Nephrol 1990;1:330.
  33. Teruel JL, Marcen R, Herrero JA, et al. An easy and effective procedure to prevent radiocntrast agent nephrotoxicity in high risk patients. Nephron 1989;51:282. Go to original source... Go to PubMed...
  34. Solomon RC, Werner C, Mann D, et al. Effects of saline, mannitol and furosemide on acute decreases in renal function induced by contrast agents. N Engl J Med 1994;331:1416-1420. Go to original source... Go to PubMed...
  35. Weinstein J, Heyman S, Brezis M. Potential deleterious effect of furosemide in radiocantrast nephropathy. Nephron 1992;62:413-415. Go to original source... Go to PubMed...
  36. Weisberg LS, Kurnik PB, Kurnik BR. Risk of radiokontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 1994;45:259-265. Go to original source... Go to PubMed...
  37. Kurnick BR, Allgren RL, Genter FC, et al. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 1998;31:674-680. Go to original source... Go to PubMed...
  38. Tepel M, van der Giet M, Schwarzwald C, et al. Prevention of radigraphic-contrastagent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343: 180-184. Go to original source... Go to PubMed...
  39. Lehnert T, Keller E, Gondolf K, et al. Effect of haemodialysis after contrast medium administration in patient with renal insufficiency. Nephrol Dial Transplant 1998;13:358-362. Go to original source... Go to PubMed...
  40. Moon SS, Back S, Kurkus J, et al. Haemodialysis for elimination of the nonionic contrast medium iohexol after angiography in patients with impaired renal function. Nephron 1995;70:430-437. Go to original source... Go to PubMed...
  41. Barrett BJ, Parfrey PS, Vavasour HM, et al. Contrast nephropathy in patients with impaired renal function:High versus low osmolar media. Kidney Int 1992;41: 1274-1279. Go to original source... Go to PubMed...
  42. Conlon PJ, Schwab SJ. Time to abandon nonionic contrast? J Am Soc Nephrol 1994;5:123-124. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.